Andrew Koff
Impact in
- Oncology top 0.1%
- Cancer-related Molecular Pathways
- Molecular Biology top 0.2%
- Ubiquitin and proteasome pathways
- Epigenetics and DNA Methylation
- RNA modifications and cancer
- DNA Repair Mechanisms
Papers in
- Oncology 80
- Cancer-related Molecular Pathways 74
-
- Epigenetics and DNA Methylation 29
- Ubiquitin and proteasome pathways 22
- DNA Repair Mechanisms 7
- RNA modifications and cancer 6
- Co-authors
- Joan Massagué (5 shared papers)Kornélia Polyák (5 shared papers)Hiroaki Kiyokawa (11 shared papers)Michael J. Solomon (2 shared papers)James M. Roberts (5 shared papers)Paul Tempst (2 shared papers)Hediye Erdjument‐Bromage (2 shared papers)J. M. Roberts (1 shared paper)
- Journals
- Molecular and Cellular Biology (13 papers)Journal of Biological Chemistry (7 papers)Genes & Development (5 papers)Cancer Research (5 papers)Cell Cycle (4 papers)
- Partner nations
- United StatesSpainSouth Africa
In The Last Decade
Andrew Koff
103 papers receiving 14.8k citations
Andrew Koff's Hit Papers
Peers
Comparison fields: 5 of 127
- Oncology 8.2k
- Molecular Biology 9.6k
- Cancer Research 1.9k
- Cell Biology 2.2k
- Developmental Neuroscience 415
Countries citing papers authored by Andrew Koff
This map shows the geographic impact of Andrew Koff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Koff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Koff more than expected).
Fields of papers citing papers by Andrew Koff
This network shows the impact of papers produced by Andrew Koff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Koff. The network helps show where Andrew Koff may publish in the future.
Co-authors
The 25 scholars most cited alongside Andrew Koff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 103 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals Hit paper breakdown → | 1994 | 1880 |
| 2 | p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. Hit paper breakdown → | 1994 | 1677 |
| 3 | Enhanced Growth of Mice Lacking the Cyclin-Dependent Kinase Inhibitor Function of p27 Hit paper breakdown → | 1996 | 1077 |
| 4 | Formation and Activation of a Cyclin E-cdk2 Complex During the G 1 Phase of the Human Cell Cycle Hit paper breakdown → | 1992 | 912 |
| 5 | Human cyclin E, a new cyclin that interacts with two members of the CDC2 gene family Hit paper breakdown → | 1991 | 567 |
| 6 | 1993 | 498 | |
| 7 | 2009 | 427 | |
| 8 | 2001 | 391 | |
| 9 | 2000 | 335 | |
| 10 | 1999 | 330 | |
| 11 | 1999 | 301 | |
| 12 | 2018 | 284 | |
| 13 | 1996 | 276 | |
| 14 | 1996 | 270 | |
| 15 | 1994 | 262 | |
| 16 | 2016 | 229 | |
| 17 | 1997 | 227 | |
| 18 | 1999 | 214 | |
| 19 | Formation of p27-CDK complexes during the human mitotic cell cycle. | 1996 | 206 |
| 20 | Involvement of p27KIP1 in G1 arrest mediated by an anti-epidermal growth factor receptor monoclonal antibody. | 1996 | 186 |
About Andrew Koff
Andrew Koff is a scholar working on Oncology, Molecular Biology, Cell Biology, Pulmonary and Respiratory Medicine and Biotechnology, having authored 103 papers that have together received 15.1k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (74 papers), Epigenetics and DNA Methylation (29 papers), Microtubule and mitosis dynamics (25 papers), Ubiquitin and proteasome pathways (22 papers), DNA Repair Mechanisms (7 papers), Cancer Research and Treatments (7 papers), Advanced Breast Cancer Therapies (6 papers) and RNA modifications and cancer (6 papers). The work is most often cited by research in Oncology (8.2k citations), Molecular Biology (9.6k citations), Cancer Research (1.9k citations), Cell Biology (2.2k citations) and Developmental Neuroscience (415 citations). Andrew Koff has collaborated with scholars based in United States, Spain and South Africa. Frequent co-authors include Joan Massagué, Kornélia Polyák, Hiroaki Kiyokawa, Michael J. Solomon, James M. Roberts, Paul Tempst, Hediye Erdjument‐Bromage, J. M. Roberts, Charles J. Sherr and Jun‐ya Kato. Their work appears in journals such as Molecular and Cellular Biology, Journal of Biological Chemistry, Genes & Development, Cancer Research and Cell Cycle.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.